Raymond James analyst Chris Meekins stated that Robert F. Kennedy Jr. as Secretary of Health and Human Services would bring increased volatility to health markets, posing challenges in navigating policy risks. President-elect Donald Trump's choice of the vaccine skeptic for the role was confirmed.